Semaglutide commonly causes nausea, vomiting, or constipation
Although reported AEs are generally not serious and safety and efficacy in older adults are generally comparable to those in younger adults [36], higher AE rates may nonetheless predispose older adults to additional risks that are more critical in this population, such as hypoglycemia, dehydration, or impaired renal function
Semaglutide injection specifics Semaglutide, whether as brand-name Ozempic/Wegovy or compounded, is a once-weekly subcutaneous injection
"Our autonomic nervous system is perhaps the most important indicator of how our body handles stress," explains Schmidt
This efficiency not only benefits the healthcare team but also enhances the patient experience by allowing for quicker initiation of therapy
In addition, increasing awareness of obesity as a chronic disease and rising demand for effective long-term weight management solutions are accelerating global market expansion